ARCHIVES

ONS Scientific Program Grows

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007